Katelyn Mulligan

Katelyn Mulligan, MS, joined ITB-MED in April 2024. She brings with her 17 years of experience in regulatory affairs (primarily regulatory operations) in the pharmaceutical industry.  Her last role was as a senior submission manager at Bristol Myers Squibb. She has worked on small molecules and biologics in all stages of development across several different therapeutic areas.  Katelyn has a master’s degree from Northeastern University in Regulatory Affairs for Drugs, Biologics, and Medical Devices.  She has a bachelor’s in journalism from Ramapo College of NJ and is currently enrolled in an executive MBA program through Quantic School of Business.